Transaction DateRecipientSharesTypePriceValue
7th December 2020Jack W Schuler35,157Exercise of derivative$6.83$240,122.31
7th December 2020Jack W Schuler23,440Exercise of derivative$6.83$160,095.20
30th October 2020Jack W Schuler753,735Conversion of derivative$14.40$10,853,784.00
30th October 2020Jack W Schuler277,777Open or private purchase$18.00$4,999,986.00
30th October 2020Jack W Schuler4,668,046Conversion of derivative$0.00
30th October 2020Jack W Schuler245,041Conversion of derivative$0.00
26th August 2020Jack W Schuler365,241Open or private purchase$4.25$1,552,274.25
1st July 2020Jack W Schuler2,285,715Open or private purchase$3.50$8,000,002.50
26th June 2020Jack W Schuler5,151,517Open or private purchase$1.65$8,500,003.05
26th June 2020Jack W Schuler2,424,242Open or private purchase$1.65$3,999,999.30
Biolase logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

BIOLASE, Inc. engages in the development, manufacture, market and sale of laser systems in dentistry and medicine. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels and other traditional dental instruments. The Diode systems performs soft tissue, pain therapy, and cosmetic procedures, including teeth whitening.

Ticker: BIOL
Sector: Healthcare
Industry: Medical Devices
SEC Central Index Key (CIK): 811240
Employees: 190
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags